corporate_banner_en

GRIFOLS BIOSCIENCE R&D SPAIN

Projects
Regions
European Union
Enlargement countries
European Free Trade Association
Mediterranean neighbourhood
FEMIP overview
Maximizing synergies
Financing & advisory services
Loans
Private equity
Advisory services
FEMIP Support Package
How to apply
Trust fund
Technical advisory
Private equity
CAMENA Climate action envelope
MED 5P
Organisation and staff
FAQ - FEMIP
EU Eastern neighbours
Cooperation with other institutions and organisations
Financing facilities
Trust fund
Examples of EPTATF Operations
Institutional framework
Central Asia
Institutional framework
Cooperation with other institutions and organisations
Financing facilities
Technical assistance and grants
Sub-Saharan Africa, Caribbean and Pacific
Funding and financial instruments
Applying for loans
Cooperation with partners
Investment Facility
Other initiatives
Activities
Asia and Latin America
Priorities
Climate
EIB and COP
Economic and Social Cohesion
Infrastructure
Innovation and skills
Investing for Youth
SMEs
Environment
Sectors
Agriculture, Food and Rural Development
Aviation
Digital economy
Education and training
Energy
Forestry
Health and Life Science
Maritime
Regional development
Roads
Trans-European Networks
Transport
Urban agenda
Water and Wastewater management
Project cycle
Applying for a loan
Appraisal
Procurement
Monitoring
Projects to be financed
Explanatory notes
Breakdown by region
European Union
EFTA countries
Enlargement countries
Eastern Europe, Southern Caucasus and Russia
Mediterranean countries
Africa, Caribbean, Pacific countries + OCT
South Africa
Asia and Latin America
Breakdown by sector
Recently approved projects
Projects financed
Breakdown by region
European Union
EFTA countries
Enlargement countries
Eastern Europe, Southern Caucasus and Russia
Mediterranean countries
Africa, Caribbean, Pacific countries + OCT
South Africa
Asia and Latin America
Breakdown by sector
Multi-criteria list
Operations evaluation
Process and methodology

GRIFOLS BIOSCIENCE R&D SPAIN

  •  Reference: 20140603
  •  Release date: 16 March 2015
Promoter – Financial Intermediary

GRIFOLS SA

Location
Description

The project covers the promoter’s research activities in the fields of plasma-derived therapies, diagnostics and medical solutions for hospitals.

Objectives

The project covers all stages of development i.e. pre-clinical development as well as clinical development. The project will be managed from the company’s headquarters in Barcelona, Spain.

Comments
 
Sector(s)
Proposed EFSI financing
EUR 100 million
Related total EFSI investment
EUR 240.9 million
Proposed EIB finance (Approximate amount)

EUR 100 million

Total cost (Approximate amount)

Not disclosed.

Environmental aspects

The project mainly concerns investments in research and development (R&D) that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU. Full environmental details will be verified during the appraisal.

Procurement

The promoter is a private company not operating in the Utilities sector and not having the status of a contracting authority. Thus it is not covered by EU directives on procurement. However, the promoter’s procurement procedures are expected to be in line with EIB guidelines for private-sector projects. The Bank’s services will verify details during the project due diligence.

Status

Signed   -   28/10/2015.


Disclaimer

The figures on this page are not part of formal EIB Group reporting on EFSI. Therefore, they are provisional and unaudited. The figures are subject to change. Approvals of EIB projects by the EIB Board of Directors are a requirement for financing negotiations with project promoters which, if successful, lead to signatures.


Project data sheets


 Print
Copyright © European Investment Bank 2016
The European Investment Bank is not responsible for the content of external internet sites.